Moe Nahir

🧬 Biotech Investor | Life Sciences Enthusiast | Trader

[Moe Nahir @BiotechMoe]

1/ 🧵 Big news from BioVaxys! $BVAXF $biov

BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium 👇 #BioVaxys #BARDA #Health #Vaccine

[Moe Nahir @BiotechMoe]

Everyone is chasing AI.

I'm watching biotech.

One positive clinical update can do more for a microcap than a year of hype.

$BVAXF $BIOV
$MRNA $BNTX $NVAX

[Moe Nahir @BiotechMoe]

Smart move accelerating vaccine work at-risk. BioVaxys DPX platform is perfect for this. $BVAXF $BIOV.CN $BIOV.NE

[Moe Nahir @BiotechMoe]

Long game here regardless. The clinical data out of Providence is not something you can just wave away, and the SpayVac and Zoetis pieces add more depth to the story than most halted micro-caps can point to. The filing timeline is the whole ballgame right now.

$BVAXF $BIOV

[Moe Nahir @BiotechMoe]

Big volume and solid pop in $BVAXF last week. Looks like some shorts finally hitting the buy button.

[Moe Nahir @BiotechMoe]

Ebola DRC outbreak equals WHO emergency. $BVAXF has historical DPX-Ebola study with 100 percent survival. Naked short pressure is real. $MRK $AEMD $EBS $REGN $BVAXF

[Moe Nahir @BiotechMoe]

Markets can suppress a chart. They can't suppress results forever. If the catalysts continue stacking up, today's sellers may become tomorrow's buyers. $BVAXF $MRK $REGN $EBS

[Moe Nahir @BiotechMoe]

Microcap biotech 101: low expectations + improving fundamentals = potential for violent repricing. Keeping $BVAXF on watch. $MRK $REGN $EBS $AEMD

[Moe Nahir @BiotechMoe]

$BVAXF DPX-Ebola results: vaccinated monkeys lived symptom-free. Naked shares have been suppressing the stock. Short squeeze time. $MRK $AEMD $EBS $REGN $BVAXF

[Moe Nahir @BiotechMoe]

Everyone sees the pressure. I'm watching the setup. Positive data, expanding visibility, and a market that may be underestimating the upside. $BVAXF $MRK $REGN $EBS $AEMD

[Moe Nahir @BiotechMoe]

The most powerful rallies often start when nobody believes they're possible. That's why I pay attention when sentiment is low but catalysts keep building. $BVAXF $MRK $REGN

[Moe Nahir @BiotechMoe]

This is the spark $BVAXF needed! With the Bundibugyo Ebola PHEIC exploding in DRC and no vaccine ready, their NIH DPX-Ebola data showing 100% survival is pure rocket fuel

[Moe Nahir @BiotechMoe]

$BVAXF is revisiting proven DPX-Ebola vaccine data amid outbreak concerns. Naked short selling cannot hide this anymore. $MRK $AEMD $EBS $REGN $BVAXF

[Moe Nahir @BiotechMoe]

Ebola news + $BVAXF dropping their strong DPX monkey study (full protection!) = potential volume spike and quick re-rating for the stock right now.

Smart timing that puts $BVAXF back on the radar alongside $MRK $REGN $EBS $AEMD.

[Moe Nahir @BiotechMoe]

This is the spark $BVAXF needed!

Expect a surge in attention, trading volume, and share price momentum as the market wakes up to this hidden platform gem $BVAXF $MRK $REGN $EBS $AEMD.

[Moe Nahir @BiotechMoe]

$BVAXF revisiting Ebola vaccine study: monkeys received DPX formulation, challenged day 70 with wild-type lethal virus. 100 percent survival, no symptoms. Controls dead in 7 days. DRC emergency now $MRK $AEMD $EBS $REGN $BVAXF

[Moe Nahir @BiotechMoe]

@biovaxys BioVaxys dropped ovarian cancer combination therapy data on May 1, roughly 20 days before the May 21 abstract release.

Worth watching whether ASCO is incremental data or the same dataset in a higher-visibility venue.

[Moe Nahir @BiotechMoe]

Frustrating to see the CSE halt, but the core @biovaxys business keeps moving.

Positive Phase 2 data in bladder & ovarian cancer, DPX platform validation, and OTC liquidity still available for shareholders outside Canada.

[Moe Nahir @BiotechMoe]

Man, brutal timing for @biovaxys

DPX data looked genuinely promising, so this filing halt feels like momentum got cut short by paperwork.

Hoping they get current fast, because the science was finally getting attention. $MRNA $BNTX #Biotech

[Moe Nahir @BiotechMoe]

@WallStSai What's the biggest mistake traders are making here?

[Moe Nahir @BiotechMoe]

Volume picking up on $BIOV / $BVAXF

Could be accumulation, could be overhang clearing.

MCTO resolution is the real tell, not the tape.

Watch what happens after.